These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
317 related articles for article (PubMed ID: 7159473)
1. Effects of the chiral isomers of erythro- and threo-9-(2-hydroxy-3-nonyl)adenine on purine metabolism in sarcoma 180 cells. Chen SF; Stoeckler JD; Choi HS; Burgess FW; Marcaccio EJ; Steen PA; Berman SF; Parks RE; Panzica RP; Abushanab E Biochem Pharmacol; 1982 Dec; 31(24):3955-60. PubMed ID: 7159473 [TBL] [Abstract][Full Text] [Related]
2. Effects of chirality in 9-(2-hydroxy-3-nonyl)adenine upon deoxyribonucleic acid synthesis in herpes simplex virus-infected cells. North TW; O'Connor L; Abushanab E; Panzica RP Biochem Pharmacol; 1983 Dec; 32(23):3541-6. PubMed ID: 6316987 [TBL] [Abstract][Full Text] [Related]
3. Adenosine deaminase inhibitors. Synthesis of deaza analogues of erythro-9-(2-hydroxy-3-nonyl)adenine. Antonini I; Cristalli G; Franchetti P; Grifantini M; Martelli S; Lupidi G; Riva F J Med Chem; 1984 Mar; 27(3):274-8. PubMed ID: 6699873 [TBL] [Abstract][Full Text] [Related]
4. Adenosine deaminase inhibitors. Synthesis and biological activity of deaza analogues of erythro-9-(2-hydroxy-3-nonyl)adenine. Cristalli G; Franchetti P; Grifantini M; Vittori S; Lupidi G; Riva F; Bordoni T; Geroni C; Verini MA J Med Chem; 1988 Feb; 31(2):390-3. PubMed ID: 3339608 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of inhibition of adenosine deaminase by erythro-9-(2-hydroxy-3-nonyl)adenine in CBA mice. Lambe CU; Nelson DJ Biochem Pharmacol; 1982 Feb; 31(4):535-9. PubMed ID: 7066021 [TBL] [Abstract][Full Text] [Related]
6. Differential cardioprotection with selective inhibitors of adenosine metabolism and transport: role of purine release in ischemic and reperfusion injury. Abd-Elfattah AS; Jessen ME; Lekven J; Wechsler AS Mol Cell Biochem; 1998 Mar; 180(1-2):179-91. PubMed ID: 9546645 [TBL] [Abstract][Full Text] [Related]
7. Mechanisms of apoptosis induced by purine nucleosides in astrocytes. Di Iorio P; Kleywegt S; Ciccarelli R; Traversa U; Andrew CM; Crocker CE; Werstiuk ES; Rathbone MP Glia; 2002 May; 38(3):179-90. PubMed ID: 11968056 [TBL] [Abstract][Full Text] [Related]
8. Profiles of purine biosynthesis, salvage and degradation in disks of potato (Solanum tuberosum L.) tubers. Katahira R; Ashihara H Planta; 2006 Dec; 225(1):115-26. PubMed ID: 16845529 [TBL] [Abstract][Full Text] [Related]
9. Optimization of the local inhibition of intestinal adenosine deaminase (ADA) by erythro-9-(2-hydroxy-3-nonyl)adenine: enhanced oral delivery of an ADA-activated prodrug for anti-HIV therapy. Singhal D; Anderson BD J Pharm Sci; 1998 May; 87(5):578-85. PubMed ID: 9572908 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of adenosine deaminase from several sources by deaza derivatives of adenosine and EHNA. Lupidi G; Cristalli G; Marmocchi F; Riva F; Grifantini M J Enzyme Inhib; 1985; 1(1):67-75. PubMed ID: 3916912 [TBL] [Abstract][Full Text] [Related]
11. Absorption and intestinal metabolism of purine dideoxynucleosides and an adenosine deaminase-activated prodrug of 2',3'-dideoxyinosine in the mesenteric vein cannulated rat ileum. Singhal D; Ho NF; Anderson BD J Pharm Sci; 1998 May; 87(5):569-77. PubMed ID: 9572907 [TBL] [Abstract][Full Text] [Related]
12. Adenosine deaminase inhibition and myocardial adenosine metabolism during ischemia. Achterberg PW; de Jong JW Adv Myocardiol; 1985; 6():465-72. PubMed ID: 3992044 [TBL] [Abstract][Full Text] [Related]
13. Characterization of a cell culture model for the study of adenosine deaminase- and purine nucleoside phosphorylase-deficient immunologic disease. Ullman B; Cohen A; Martin DW Cell; 1976 Oct; 9(2):205-11. PubMed ID: 184961 [TBL] [Abstract][Full Text] [Related]
14. Sedative and electroencephalographic actions of erythro-9-(2-hydroxy-3-nonyl)-adenine (EHNA): relationship to inhibition of brain adenosine deaminase. Mendelson WB; Kuruvilla A; Watlington T; Goehl K; Paul SM; Skolnick P Psychopharmacology (Berl); 1983; 79(2-3):126-9. PubMed ID: 6405420 [TBL] [Abstract][Full Text] [Related]
15. Purine salvage networks in Giardia lamblia. Wang CC; Aldritt S J Exp Med; 1983 Nov; 158(5):1703-12. PubMed ID: 6605408 [TBL] [Abstract][Full Text] [Related]
16. Effect of chirality in erythro-9-(2-hydroxy-3-nonyl) adenine (EHNA) on adenosine deaminase inhibition. Bessodes M; Bastian G; Abushanab E; Panzica RP; Berman SF; Marcaccio EJ; Chen SF; Stoeckler JD; Parks RE Biochem Pharmacol; 1982 Mar; 31(5):879-82. PubMed ID: 7082355 [No Abstract] [Full Text] [Related]
17. Purine nucleotide metabolism in resident and activated rat macrophages in vitro. Barankiewicz J; Cohen A Eur J Immunol; 1985 Jun; 15(6):627-31. PubMed ID: 2408899 [TBL] [Abstract][Full Text] [Related]
18. Kinetics of inhibition of calf intestinal adenosine deaminase by (+)- and (-)-erythro-9-(2-hydroxy-3-nonyl)adenine. Porter DJ; Abushanab E Biochemistry; 1992 Sep; 31(35):8216-20. PubMed ID: 1525161 [TBL] [Abstract][Full Text] [Related]
19. Purine metabolism in the intact sporozoites and merozoites of Eimeria tenella. LaFon SW; Nelson DJ Mol Biochem Parasitol; 1985 Jan; 14(1):11-22. PubMed ID: 2580236 [TBL] [Abstract][Full Text] [Related]
20. Purine salvage in Schistosoma mansoni schistosomules. Dovey HF; McKerrow JH; Wang CC Mol Biochem Parasitol; 1984 Apr; 11():157-67. PubMed ID: 6431283 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]